![]() |
Volumn 20, Issue 29, 2001, Pages 3786-3797
|
Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: Induction of endoreplication following prophase arrest
|
Author keywords
Cancer; Cyclin dependent kinase; Glycogen synthase kinase; GSK 3 ; Indirubin; Kinase inhibitor
|
Indexed keywords
CYCLIN B;
CYCLIN DEPENDENT KINASE 1;
CYCLIN DEPENDENT KINASE INHIBITOR;
DANGGUI LONGHUI WAN;
GLYCOGEN SYNTHASE KINASE 3;
GLYCOGEN SYNTHASE KINASE 3BETA;
HERBACEOUS AGENT;
INDIRUBIN;
INDIRUBIN 3' MONOXIME;
NOCODAZOLE;
QING DAI;
UNCLASSIFIED DRUG;
ARTICLE;
CELL CYCLE G2 PHASE;
CELL DEATH;
CONTROLLED STUDY;
DNA CONTENT;
ENZYME INHIBITION;
ENZYME PHOSPHORYLATION;
HUMAN;
HUMAN CELL;
MITOSIS INHIBITION;
PRIORITY JOURNAL;
PROPHASE;
SIGNAL TRANSDUCTION;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE;
CDC2 PROTEIN KINASE;
CELL CYCLE PROTEINS;
CELL DEATH;
CELL LINE, TRANSFORMED;
CYCLIN B;
G2 PHASE;
GENE EXPRESSION;
GLYCOGEN SYNTHASE KINASE 3;
GLYCOGEN SYNTHASE KINASES;
GROWTH INHIBITORS;
HUMANS;
INDOLES;
MITOSIS;
MOLECULAR STRUCTURE;
NOCODAZOLE;
POLYPLOIDY;
PROPHASE;
|
EID: 0035963318
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204503 Document Type: Article |
Times cited : (145)
|
References (43)
|